vs
GRAFTECH INTERNATIONAL LTD（EAF）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是GRAFTECH INTERNATIONAL LTD的1.6倍（$197.9M vs $125.1M），REPLIGEN CORP净利率更高（6.7% vs -34.6%，领先41.3%），REPLIGEN CORP同比增速更快（13.6% vs 11.9%），REPLIGEN CORP自由现金流更多（$17.6M vs $-27.1M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -4.6%）
格瑞泰克国际有限公司是石墨电极与石油焦生产商，其产品是电弧炉炼钢及其他金属生产的核心原材料。公司总部位于俄亥俄州布鲁克林海茨，在法国加来、西班牙潘普洛纳、墨西哥蒙特雷以及美国宾夕法尼亚州圣玛丽斯均设有生产基地。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
EAF vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.6倍
$125.1M
营收增速更快
RGEN
高出1.8%
11.9%
净利率更高
RGEN
高出41.3%
-34.6%
自由现金流更多
RGEN
多$44.6M
$-27.1M
两年增速更快
RGEN
近两年复合增速
-4.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $125.1M | $197.9M |
| 净利润 | $-43.3M | $13.3M |
| 毛利率 | -7.8% | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | -34.6% | 6.7% |
| 营收同比 | 11.9% | 13.6% |
| 净利润同比 | -10.0% | 143.9% |
| 每股收益（稀释后） | — | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EAFRGEN
| Q1 26 | $125.1M | — | ||
| Q4 25 | $116.5M | $197.9M | ||
| Q3 25 | $144.0M | $188.8M | ||
| Q2 25 | $131.8M | $182.4M | ||
| Q1 25 | $111.8M | $169.2M | ||
| Q4 24 | $134.2M | $174.1M | ||
| Q3 24 | $130.7M | $154.9M | ||
| Q2 24 | $137.3M | $154.1M |
净利润EAFRGEN
| Q1 26 | $-43.3M | — | ||
| Q4 25 | $-65.1M | $13.3M | ||
| Q3 25 | $-28.5M | $14.9M | ||
| Q2 25 | $-86.9M | $14.9M | ||
| Q1 25 | $-39.4M | $5.8M | ||
| Q4 24 | $-49.5M | $-30.3M | ||
| Q3 24 | $-36.1M | $-654.0K | ||
| Q2 24 | $-14.8M | $3.3M |
毛利率EAFRGEN
| Q1 26 | -7.8% | — | ||
| Q4 25 | -20.9% | 52.5% | ||
| Q3 25 | 7.2% | 53.2% | ||
| Q2 25 | 0.0% | 50.0% | ||
| Q1 25 | -1.5% | 53.6% | ||
| Q4 24 | -7.8% | 26.1% | ||
| Q3 24 | -9.2% | 50.0% | ||
| Q2 24 | 2.9% | 49.8% |
营业利润率EAFRGEN
| Q1 26 | — | — | ||
| Q4 25 | -33.6% | 9.0% | ||
| Q3 25 | -3.6% | 8.9% | ||
| Q2 25 | -11.0% | 7.6% | ||
| Q1 25 | -16.3% | 3.9% | ||
| Q4 24 | -18.6% | -17.7% | ||
| Q3 24 | -20.1% | -5.1% | ||
| Q2 24 | -2.0% | 1.0% |
净利率EAFRGEN
| Q1 26 | -34.6% | — | ||
| Q4 25 | -55.9% | 6.7% | ||
| Q3 25 | -19.8% | 7.9% | ||
| Q2 25 | -65.9% | 8.2% | ||
| Q1 25 | -35.2% | 3.4% | ||
| Q4 24 | -36.9% | -17.4% | ||
| Q3 24 | -27.6% | -0.4% | ||
| Q2 24 | -10.7% | 2.2% |
每股收益（稀释后）EAFRGEN
| Q1 26 | — | — | ||
| Q4 25 | $-6.86 | $0.24 | ||
| Q3 25 | $-1.10 | $0.26 | ||
| Q2 25 | $-0.34 | $0.26 | ||
| Q1 25 | $-0.15 | $0.10 | ||
| Q4 24 | $-3.51 | $-0.55 | ||
| Q3 24 | $-1.40 | $-0.01 | ||
| Q2 24 | $-0.06 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $120.2M | $767.6M |
| 总债务越低越好 | $1.1B | $542.2M |
| 股东权益账面价值 | — | $2.1B |
| 总资产 | $997.2M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资EAFRGEN
| Q1 26 | $120.2M | — | ||
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | $120.7M | $809.1M |
总债务EAFRGEN
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | $542.2M | ||
| Q3 25 | $1.1B | $537.9M | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | $525.6M | ||
| Q3 24 | $929.5M | — | ||
| Q2 24 | $928.2M | — |
股东权益EAFRGEN
| Q1 26 | — | — | ||
| Q4 25 | $-259.6M | $2.1B | ||
| Q3 25 | $-194.4M | $2.1B | ||
| Q2 25 | $-168.4M | $2.1B | ||
| Q1 25 | $-105.3M | $2.0B | ||
| Q4 24 | $-78.9M | $2.0B | ||
| Q3 24 | $-9.0M | $2.0B | ||
| Q2 24 | $16.2M | $2.0B |
总资产EAFRGEN
| Q1 26 | $997.2M | — | ||
| Q4 25 | $1.0B | $2.9B | ||
| Q3 25 | $1.1B | $2.9B | ||
| Q2 25 | $1.1B | $2.9B | ||
| Q1 25 | $1.2B | $2.9B | ||
| Q4 24 | $1.2B | $2.8B | ||
| Q3 24 | $1.1B | $2.8B | ||
| Q2 24 | $1.2B | $2.9B |
负债/权益比EAFRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | 57.16× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.9M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-27.1M | $17.6M |
| 自由现金流率自由现金流/营收 | -21.6% | 8.9% |
| 资本支出强度资本支出/营收 | 9.7% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $-105.1M | $93.9M |
8季度趋势，按日历期对齐
经营现金流EAFRGEN
| Q1 26 | $-14.9M | — | ||
| Q4 25 | $-20.9M | $25.7M | ||
| Q3 25 | $24.7M | $48.1M | ||
| Q2 25 | $-53.2M | $28.6M | ||
| Q1 25 | $-32.2M | $15.0M | ||
| Q4 24 | $-26.4M | $39.2M | ||
| Q3 24 | $23.7M | $49.3M | ||
| Q2 24 | $-36.9M | $42.2M |
自由现金流EAFRGEN
| Q1 26 | $-27.1M | — | ||
| Q4 25 | $-39.3M | $17.6M | ||
| Q3 25 | $18.4M | $43.4M | ||
| Q2 25 | $-57.1M | $21.5M | ||
| Q1 25 | $-42.5M | $11.4M | ||
| Q4 24 | $-39.2M | $33.6M | ||
| Q3 24 | $19.7M | $42.3M | ||
| Q2 24 | $-43.8M | $37.4M |
自由现金流率EAFRGEN
| Q1 26 | -21.6% | — | ||
| Q4 25 | -33.7% | 8.9% | ||
| Q3 25 | 12.8% | 23.0% | ||
| Q2 25 | -43.3% | 11.8% | ||
| Q1 25 | -38.0% | 6.8% | ||
| Q4 24 | -29.2% | 19.3% | ||
| Q3 24 | 15.1% | 27.3% | ||
| Q2 24 | -31.9% | 24.3% |
资本支出强度EAFRGEN
| Q1 26 | 9.7% | — | ||
| Q4 25 | 15.8% | 4.1% | ||
| Q3 25 | 4.4% | 2.5% | ||
| Q2 25 | 3.0% | 3.9% | ||
| Q1 25 | 9.2% | 2.1% | ||
| Q4 24 | 9.5% | 3.2% | ||
| Q3 24 | 3.1% | 4.5% | ||
| Q2 24 | 5.1% | 3.1% |
现金转化率EAFRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
